AccessAfrica 2 is a Horizon Europe project (2023-2026) that aims to enhance ethical review and regulatory capacity for clinical trials in two Sub-Saharan African (SSA) countries. The project specifically focuses on the review and oversight of reported adverse events during clinical trials, improving the efficiencies of the National Ethics Committees (NECs) and National Regulatory Authorities (NRAs), and equipping them with the skills and knowledge necessary for improved operations during outbreaks and epidemics. The project involves collaboration with five partners from universities and research institutions, with the University of Oslo serving as the coordinating institution.
Additionally, AccessAfrica 2 has received funding from the Global Health EDCTP3.
Company Details
- Founded
- -
- Address
- Kirkeveien 166, Oslo,norway
- Industry
- Research Services
- NAICS
-
Scientific Research and Development ServicesResearch and Development in the Physical, Engineering, and Life SciencesResearch and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Website
- https://www.accessafrica.uio.no/
- HQ
- Oslo
Accessafrica 2 Questions
Accessafrica 2's website is https://www.accessafrica.uio.no/
Accessafrica 2's LinkedIn profile is https://no.linkedin.com/company/accessafrica-2
Accessafrica 2's industry is
Research Services
Accessafrica 2's top competitors are
Trafford Research,
European & Developing Countries Clinical Trials Partnership (Edctp).
Accessafrica 2's categories are Research Services
Accessafrica 2's founding year is 2023
